PROTHENA CORP PUBLIC LTD CO (PRTA) Form 10-K Annual Reports
PROTHENA CORP PUBLIC LTD CO (PRTA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PRTA
CIK: 1559053
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L2
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJason Trimborn
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-13 | PRIMARY DOCUMENT | 0001045463-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | PRIMARY DOCUMENT | 0001045463-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | PRIMARY DOCUMENT | 0001045463-26-000019 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-02 | 8-K | 0001559053-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-29 | PRIMARY DOCUMENT | 0001045463-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | PRIMARY DOCUMENT | 0001045463-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-18 | PRIMARY DOCUMENT | 0001045463-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | PRIMARY DOCUMENT | 0001045463-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-20 | PRIMARY DOCUMENT | 0001045463-26-000014 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-19 | — | SCHEDULE 13G/A Filing | 0002011420-26-000007 | View SEC Doc Filr Page |
| 3 | 2026-08-18 | 2026-08-18 | PRIMARY DOCUMENT | 0002011420-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-18 | PRIMARY DOCUMENT | 0001045463-26-000013 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0002011420-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | PRIMARY DOCUMENT | 0001045463-26-000011 | View SEC Doc Filr Page |
| 3 | 2026-08-11 | 2026-08-06 | PRIMARY DOCUMENT | 0002011420-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | PRIMARY DOCUMENT | 0001045463-26-000010 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001559053-26-000022 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001559053-26-000021 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002104 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0000905148-26-003417 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0000905148-26-003416 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0000905148-26-003415 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0000905148-26-003414 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0000905148-26-003413 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0000905148-26-003412 | View SEC Doc Filr Page |